Kenji Ohwaki
- Physiology top 10%
- Nitric Oxide and Endothelin Effects 4
-
- Diabetes Treatment and Management 8
- Diabetes Management and Research 4
- Immunology and Allergy top 10%
-
- Atherosclerosis and Cardiovascular Diseases 3
-
- Chemokine receptors and signaling 5
-
- Metabolism, Diabetes, and Cancer 4
- Peroxisome Proliferator-Activated Receptors 3
-
- Antimicrobial Peptides and Activities 3
Kenji Ohwaki
27 papers receiving 839 citations
Peers
Comparison fields: 5 of 94
- Physiology 237
- Endocrinology, Diabetes and Metabolism 136
- Immunology and Allergy 47
- Immunology 139
- Cancer Research 78
Countries citing papers authored by Kenji Ohwaki
This map shows the geographic impact of Kenji Ohwaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenji Ohwaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenji Ohwaki more than expected).
Fields of papers citing papers by Kenji Ohwaki
This network shows the impact of papers produced by Kenji Ohwaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenji Ohwaki. The network helps show where Kenji Ohwaki may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kenji Ohwaki, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2021 | 50 | |
| 4 | 2020 | 5 | |
| 5 | 2017 | 3 | |
| 6 | 2012 | 39 | |
| 7 | 2009 | 31 | |
| 8 | 2008 | 37 | |
| 9 | 2008 | 47 | |
| 10 | 2007 | 108 | |
| 11 | 2003 | 56 | |
| 12 | 2003 | 31 | |
| 13 | 2003 | 1 | |
| 14 | 2001 | 22 | |
| 15 | 1997 | 33 | |
| 16 | 1995 | 32 | |
| 17 | 1995 | 65 | |
| 18 | 1994 | 2 | |
| 19 | 1994 | 1 | |
| 20 | 1991 | 1 |
About Kenji Ohwaki
Kenji Ohwaki is a scholar working on Immunology and Allergy, Microbiology and Endocrinology, Diabetes and Metabolism, having authored 30 papers that have together received 866 indexed citations. Recurring topics across this work include Diabetes Treatment and Management (8 papers), Chemokine receptors and signaling (5 papers), Nitric Oxide and Endothelin Effects (4 papers), Diabetes Management and Research (4 papers), Metabolism, Diabetes, and Cancer (4 papers), Antimicrobial Peptides and Activities (3 papers), Atherosclerosis and Cardiovascular Diseases (3 papers) and Peroxisome Proliferator-Activated Receptors (3 papers). The work is most often cited by research in Physiology (237 citations), Endocrinology, Diabetes and Metabolism (136 citations) and Immunology and Allergy (47 citations). Kenji Ohwaki has collaborated with scholars based in Japan, United States and Singapore. Frequent co-authors include Toshihiko Saeki, Akira Naya, Norikazu Ohtake, Kazuhito Noguchi, Makoto Ishikawa, Satoshi Ozaki, Kiyofumi Ishikawa, Jun Kusunoki, M. Ihara and M. Yano. Their work appears in journals such as Journal of Clinical Investigation, PLoS ONE and Circulation Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.